We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venn Life Sciences Holdings Plc | LSE:VENN | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.85 | 6.70 | 7.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/7/2019 12:10 | FYI - New thread under #ORPH | ruigloria | |
26/6/2019 21:45 | Justin white | elliotset | |
24/6/2019 18:05 | Looking good here l, ii taken position over 5p ... heading to double digits in the next week or so... news will start flowing | rakepat37 | |
24/6/2019 15:03 | JW ramp fail here. Bids his main stock great RNS just now. | tidy 2 | |
24/6/2019 11:01 | hamida No, it is spelt Winnifroth. You can't have been around investing for long. Try looking up 'satire' in the dictionary. | yump | |
24/6/2019 10:14 | Hard to buy as going into NT | rakepat37 | |
24/6/2019 09:33 | The 300k is a buy | jungmana | |
24/6/2019 09:13 | Tidy - this will be 10p by the time you wake up | jungmana | |
24/6/2019 08:12 | JW latest pump this one peeps. Gla. | tidy 2 | |
24/6/2019 08:02 | Nice summary tgere by JW. Huge potential here and right now is undervalued based on revenues alone | jungmana | |
24/6/2019 07:57 | IQAIRE: Compare to RENX, Cap. £153.4m.So judging by where they're at, IQAI should be £70M mcap which is about 80p so if we do get FDA approval this could well reach 20p initially - very much undervalued.Strong Buy | ahmedbin69 | |
24/6/2019 07:57 | And forget all the fancy talk from the know it alls, and their business ANALysis. | escapetohome | |
24/6/2019 07:56 | You see what i mean , 10 bagger + for me. TIMING not “ investment “. Put that at the top of your list! | escapetohome | |
24/6/2019 07:36 | Looking good ... should hit mid 7 then away we go | rakepat37 | |
24/6/2019 07:21 | Look at the 3 yr chart...massive upside | montynj | |
21/6/2019 11:07 | Apparently VENN was 'under-capitalised'. That's why their revenue dropped, although there isn't any explanation of exactly how that process worked. No quotes of 'this that and the other potential client wouldn't give us the contract because our balance sheet looked rubbish'. Believe that and you'll believe anything. 'Orphan drugs': the ones nobody will touch because they require government or other subsidy (new shareholders ??) to make them commercially viable. | yump | |
21/6/2019 11:00 | Much more to come because Winnifroth has shares. I wonder what price they were bought at... | yump | |
13/6/2019 19:37 | Venn Life Sciences – shares restored at a massive premium… but much more to come | aishah | |
13/6/2019 19:31 | So what's the verdict on the corporate action? (Given I'm an existing long suffering holder of Venn)? | jpuff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions